Clinical Trial Update: Postmarketing Safety Study of Hemoporfin in Patients With Port Wine Stain [Phase 4]

View source ↗

Summary

Postmarketing safety study updating safety profile of Hemoporfin in port-wine stain patients (Phase 4) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Port-wine Stain

Drugs mentioned

• Hemoporfin

Snippet

Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Conditions: Port-Wine Stain | Phase 4 | Status: COMPLETED